Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 54Genitourinary 29Other hematologic neoplasm 16Plasma cell 5Tumor-Agnostic 4Myeloid 4Dermatologic 4Thoracic 3Other solid neoplasm 2Gynecologic 2Breast 2Sarcoma 1Other neoplasm 1Gastrointestinal 1Classical hematology 1

Conditions

Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 217Fluorouracil 141Oxaliplatin 131Capecitabine 122pembrolizumab 113Irinotecan 109Leucovorin 103Bevacizumab 98Nivolumab 80130-nm albumin-bound paclitaxel 80Cisplatin 79Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 49Carboplatin 47Magnetic Resonance Spectroscopy 43Specimen Handling 39Docetaxel 37Taxes 36Radiation 34fludarabine 33Ipilimumab 33Erlotinib Hydrochloride 33durvalumab 32Biopsy 32Folfox protocol 28Radiosurgery 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Prednisone × Gastrointestinal × Clear all
NCT05084859 2024-08-09

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Biosplice Therapeutics, Inc.

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡